Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy

The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DIETER LOHMANN, ANDREAS ROLFS, JORGRISTIAN HEINRICH, JANEK TEUBNER, HENRIK DIEKS, RUDOLF FAHRIG
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DIETER LOHMANN
ANDREAS ROLFS
JORGRISTIAN HEINRICH
JANEK TEUBNER
HENRIK DIEKS
RUDOLF FAHRIG
description The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation of resistance in the case of cytotstatic treatment of a cancer patient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2007283729A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2007283729A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2007283729A13</originalsourceid><addsrcrecordid>eNqNirEKwjAURbs4iPoPD5yF2g7VsYji5KSTQwnpbQ3EvJCXCP17U_ADnO49nLMsnrekLVhMD6GBA0nyPkDEuJEyBvRJzz--QD0-sOzfcJF4yE6MROU0yDjSU-RM0ei5DcpP62IxKCvY_HZVbC_n--m6g-cO4pWGQ-zaR1WWTXWom-rY7uv_qi_aET1B</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy</title><source>esp@cenet</source><creator>DIETER LOHMANN ; ANDREAS ROLFS ; JORGRISTIAN HEINRICH ; JANEK TEUBNER ; HENRIK DIEKS ; RUDOLF FAHRIG</creator><creatorcontrib>DIETER LOHMANN ; ANDREAS ROLFS ; JORGRISTIAN HEINRICH ; JANEK TEUBNER ; HENRIK DIEKS ; RUDOLF FAHRIG</creatorcontrib><description>The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation of resistance in the case of cytotstatic treatment of a cancer patient.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080214&amp;DB=EPODOC&amp;CC=AU&amp;NR=2007283729A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080214&amp;DB=EPODOC&amp;CC=AU&amp;NR=2007283729A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DIETER LOHMANN</creatorcontrib><creatorcontrib>ANDREAS ROLFS</creatorcontrib><creatorcontrib>JORGRISTIAN HEINRICH</creatorcontrib><creatorcontrib>JANEK TEUBNER</creatorcontrib><creatorcontrib>HENRIK DIEKS</creatorcontrib><creatorcontrib>RUDOLF FAHRIG</creatorcontrib><title>Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy</title><description>The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation of resistance in the case of cytotstatic treatment of a cancer patient.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAURbs4iPoPD5yF2g7VsYji5KSTQwnpbQ3EvJCXCP17U_ADnO49nLMsnrekLVhMD6GBA0nyPkDEuJEyBvRJzz--QD0-sOzfcJF4yE6MROU0yDjSU-RM0ei5DcpP62IxKCvY_HZVbC_n--m6g-cO4pWGQ-zaR1WWTXWom-rY7uv_qi_aET1B</recordid><startdate>20080214</startdate><enddate>20080214</enddate><creator>DIETER LOHMANN</creator><creator>ANDREAS ROLFS</creator><creator>JORGRISTIAN HEINRICH</creator><creator>JANEK TEUBNER</creator><creator>HENRIK DIEKS</creator><creator>RUDOLF FAHRIG</creator><scope>EVB</scope></search><sort><creationdate>20080214</creationdate><title>Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy</title><author>DIETER LOHMANN ; ANDREAS ROLFS ; JORGRISTIAN HEINRICH ; JANEK TEUBNER ; HENRIK DIEKS ; RUDOLF FAHRIG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2007283729A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DIETER LOHMANN</creatorcontrib><creatorcontrib>ANDREAS ROLFS</creatorcontrib><creatorcontrib>JORGRISTIAN HEINRICH</creatorcontrib><creatorcontrib>JANEK TEUBNER</creatorcontrib><creatorcontrib>HENRIK DIEKS</creatorcontrib><creatorcontrib>RUDOLF FAHRIG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DIETER LOHMANN</au><au>ANDREAS ROLFS</au><au>JORGRISTIAN HEINRICH</au><au>JANEK TEUBNER</au><au>HENRIK DIEKS</au><au>RUDOLF FAHRIG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy</title><date>2008-02-14</date><risdate>2008</risdate><abstract>The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation of resistance in the case of cytotstatic treatment of a cancer patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2007283729A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A04%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DIETER%20LOHMANN&rft.date=2008-02-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2007283729A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true